查看文章

BACKGROUND: The CD34+ cell content is a predictive factor for engraftment and survival after umbilical cord blood (UCB) transplantation. The high variability in the CD34 assay results in different recommended cell doses for infusion across transplant centers and also limits the clinical utility of the CD34+ cell counts provided by cord blood banks (CBBs). This bi‐institutional study was intended to understand the sources of this variability.

STUDY DESIGN AND METHODS: The level of CD34 agreement between the University of Minnesota (UM) and the Madrid CBB (MCBB) was evaluated on 50 UCB units before and after cryopreservation. Two cryopreserved vials per unit were thawed and processed at both laboratories. Dual‐platform ISHAGE‐based flow cytometry was used for CD34 enumeration.

RESULTS: Postthaw nucleated cell recoveries were similar. However, whereas CD34+ cell enumeration before …